Impact of COVID-19 pandemic on the treatment of prostate cancer in Brazilian public health system, comparing pre and post pandemic data. This is an ASCO Meeting Abstract from the 2025 ASCO ...
A Phase II trial evaluated the safety, efficacy and side-effect profile of three different dosing regimens of the albiglutide. This was a randomized, double-blind trial enrolling 356 subjects with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback